This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Baxter (BAX) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Will BAX's Q4 Earnings Reflect Its Efforts to Counter Headwinds?
by Zacks Equity Research
Baxter might have faced fourth-quarter hurdles from Hurricane Helene. However, it expects growth in infusion therapies, pharmaceuticals and patient support systems to have driven recovery.
Countdown to Baxter (BAX) Q4 Earnings: Wall Street Forecasts for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Baxter (BAX) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
New Strong Sell Stocks for January 27th
by Zacks Equity Research
BASFY, BNPQY and BAX have been added to the Zacks Rank #5 (Strong Sell) List on January 27, 2024.
Alcoa and Baxter in the Box have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Alcoa and Baxter in the Box have been highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Baxter (BAX)
by David Bartosiak
The recent earnings trend has been troubling. Can the company turn it around next year?
Baxter Stock May Gain Following Five New Injectable Product Launches
by Zacks Equity Research
BAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business segment.
Is the Options Market Predicting a Spike in Baxter International (BAX) Stock?
by Zacks Equity Research
Investors need to pay close attention to Baxter International (BAX) stock based on the movements in the options market lately.
New Strong Sell Stocks for November 29th
by Zacks Equity Research
BALY, BAX and CENTA have been added to the Zacks Rank #5 (Strong Sell) List on November 29, 2024.
New Strong Sell Stocks for November 21st
by Zacks Equity Research
BATRA, BAX and BRKR have been added to the Zacks Rank #5 (Strong Sell) List on November 21, 2024.